NASDAQ:CVKD

Cadrenal Therapeutics Stock Forecast

etoro logo Buy CVKD
*Your capital is at risk
$3.50
+0.400 (+12.90%)
At Close: Jun 18, 2026
AI Analysis AI Analysis of CVKD AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CVKD to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Volatile ride for Cadrenal Therapeutics, Inc. stock price on Thursday moving between $3.19 and $3.60
(Updated on Jun 18, 2026)

Sell candidate since May 08, 2026 Loss -42.53%

The Cadrenal Therapeutics, Inc. stock price gained 12.90% on the last trading day (Thursday, 18th Jun 2026), rising from $3.10 to $3.50. During the last trading day the stock fluctuated 12.85% from a day low at $3.19 to a day high of $3.60. The price has fallen in 6 of the last 10 days and is down by -18.79% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 27 thousand more shares were traded than the day before. In total, 115 thousand shares were bought and sold for approximately $403.24 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -21.00% during the next 3 months and, with a 90% probability hold a price between $2.27 and $4.61 at the end of this 3-month period.

CVKD Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 16, 2026, and so far it has risen 15.13%. Further rise is indicated until a new top pivot has been found. Cadrenal Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cadrenal Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.55 and $4.88. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Cadrenal Therapeutics, Inc. stock

Cadrenal Therapeutics, Inc. finds support from accumulated volume at $3.33 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.410 between high and low, or 12.85%. For the last week, the stock has had daily average volatility of 17.44%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CVKD) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Cadrenal Therapeutics, Inc. to open at $3.43, and during the day (based on 14 day Average True Range), to move between $3.26 and $3.74, which gives a possible trading interval of +/-$0.488 (+/-14.99%) up or down from last closing price. If Cadrenal Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 14.99% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.33 (4.86%) than the resistance at $3.70 (5.71%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cadrenal Therapeutics, Inc. stock A Buy?

Cadrenal Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.057 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $3.43 ( 2.00%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CVKD Performance

Trading levels for CVKD

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.84 9.71%
R2 3.68 5.24%
R1 3.59 2.47%
Price 3.50
S1 3.27 -6.47%
S2 3.18 -9.24%
S3 3.02 -13.71%

Accumulated Volume Support & Resistance Levels

Level Price
R3 4.35 24.29%
R2 4.21 20.29%
R1 3.70 5.71%
Price 3.50
S1 3.33 -4.86%
S2 3.10 -11.43%
S3 3.04 -13.14%

FAQ

What is the symbol for Cadrenal Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Cadrenal Therapeutics, Inc. is CVKD and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cadrenal Therapeutics, Inc. Stock?
Cadrenal Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Cadrenal Therapeutics, Inc. Stock?
Cadrenal Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cadrenal Therapeutics, Inc. Stock.

What's the current price of Cadrenal Therapeutics, Inc. Stock?
As of the end of day on the Jun 18, 2026, the price of an Cadrenal Therapeutics, Inc. (CVKD) share was $3.50.

What is the 52-week high and low for Cadrenal Therapeutics, Inc. Stock?
The 52-week high for Cadrenal Therapeutics, Inc. Stock is $14.64 and the 52-week low is $3.04.

What is the market capitalization of Cadrenal Therapeutics, Inc. Stock?
As of the Jun 18, 2026, the market capitalization of Cadrenal Therapeutics, Inc. is 10.039M.

When is the next earnings date for Cadrenal Therapeutics, Inc.?
The upcoming earnings date for Cadrenal Therapeutics, Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE